GHK-Cu: The Copper Peptide the Body Already Makes

The short version

GHK-Cu is a copper peptide — three amino acids (glycine, histidine, lysine) bound tightly to a copper ion. Your body already makes small amounts of it; it occurs naturally in human plasma and is part of the same collagen protein that gives skin its structure. As a topical cosmetic ingredient (usually listed as copper tripeptide-1), it has a long safety record and is one of the more heavily studied "matrix-building" peptides in the skincare-research literature.

In laboratory work, GHK-Cu increases production of collagen, elastin, and other structural proteins in skin cells ^[7]. In small human trials, topical GHK-Cu increased procollagen synthesis in about 70% of treated people, compared with 50% for vitamin C and 40% for retinoic acid in the same comparison ^[1][4]. A combination product containing the related GHK peptide also produced a statistically significant increase in hair count in a 6-month, placebo-controlled trial ^[3]. Injecting GHK-Cu into the body, rather than applying it to skin, is a different and far less studied practice — this page is explicit about where the evidence stops.

What it is

Chemically, GHK-Cu is the tripeptide glycyl-L-histidyl-L-lysine (GHK) chelated one-to-one with a copper(II) ion, forming a small, stable, positively charged complex (molecular formula C14H23CuN6O4+). The GHK sequence is not invented — it occurs naturally within the alpha-2 chain of human type I collagen and in a matrix protein called SPARC, which is one reason researchers believe the body may release it locally as a signal that tissue needs repair.

Because it is so small and water-soluble, GHK-Cu does not cross intact skin easily on its own — a 2025 review flags this poor stratum-corneum permeability (a measure called clogP of -2.24) as the central formulation challenge, and describes strategies like chemically modifying the peptide (palmitoylation) or pretreating skin with microneedles to get more of it into the tissue ^[1]. This delivery problem is one reason the field has not simply settled the question of how well topical GHK-Cu performs — how much actually reaches the target cells varies a great deal by formulation.

How it works

GHK-Cu appears to do two things at once. First, it acts as a copper chaperone — it carries a copper ion into tissue, where copper is required for the enzyme (lysyl oxidase) that cross-links newly made collagen and elastin into a strong, durable matrix, and for an antioxidant enzyme (superoxide dismutase) that helps clean up cell-damaging free radicals. Second, and separately from the copper delivery, GHK-Cu appears to act as a signaling molecule in its own right: gene-expression studies report that it changes the activity of roughly 31% of human genes at a 50%-or-greater threshold, tilting the balance toward wound-repair, DNA-repair, and antioxidant programs and away from inflammatory signaling ^[2].

In skin specifically, this translates into stimulated collagen, elastin, and glycosaminoglycan synthesis by dermal fibroblasts, along with effects on keratinocytes and the dermal papilla cells that anchor hair follicles — which is the mechanistic basis for both the anti-aging and hair-growth research described below. A widely repeated figure claiming GHK affects "about 4,000 genes" is an extrapolation beyond what the underlying data actually show at a strict statistical threshold; the more defensible number, at the 50%-or-greater change cutoff, is on the order of 2,100 genes ^[2].

What the research shows

Anti-wrinkle and collagen synthesis. A 2025 review of GHK's topical use for wrinkles found that procollagen synthesis increased in 70% of subjects using GHK-Cu, compared with 50% for vitamin C and 40% for retinoic acid tested the same way — while also documenting the delivery problem directly: through intact skin roughly no GHK-Cu penetrates, whereas microneedle pretreatment allowed about 134 nmol to permeate ^[1].

Hair growth. In a 6-month, randomized, placebo-controlled trial of 45 men with androgenetic (pattern) hair loss, a combination of 5-aminolevulinic acid and the GHK peptide increased hair count by 52.6 (at the 100 mg/mL concentration) and 71.5 (at 50 mg/mL), against 9.6 for placebo — a statistically significant difference (p<0.05), with no adverse events reported in any group ^[3]. This is a combination product, not pure GHK-Cu alone, but it is the strongest controlled human efficacy signal for a GHK-containing topical on record.

Skin regeneration, broadly. A widely cited 2015 review describes GHK-Cu stimulating synthesis of collagen, dermatan sulfate, chondroitin sulfate, and the proteoglossin decorin, and documents that plasma GHK naturally declines with age — from about 200 ng/mL at 20 years old to about 80 ng/mL by 60 ^[4]. A 2011 human skin-penetration study quantified how much copper from GHK-Cu actually gets into skin: over 48 hours, roughly 136 micrograms per square centimeter permeated, with about 97 retained as a depot in the dermis ^[5].

Foundational mechanism work. A 2008 review lays out GHK-Cu's broad tissue-remodeling profile — increased collagen, elastin, and blood-vessel-forming (VEGF, FGF-2) signals, alongside reduced markers of inflammation and oxidative stress, across many wound-healing models and in humans ^[6]. The earliest foundational study, from 1988, showed GHK-Cu increased collagen synthesis in human skin-cell cultures in a dose-dependent way, with the effect beginning at extraordinarily low (picomolar) concentrations and maxing out around one nanomolar — without simply increasing the number of cells, which suggested a genuinely targeted metabolic effect rather than nonspecific cell growth ^[7].

Reported effects, cautions & safety

Reported effects (anecdotal, not clinical evidence) — this is what people in skincare and research communities say about their own experience, not a measured trial outcome. The single most common thing people describe with topical copper-peptide (GHK-Cu) products is skin that feels firmer and more elastic, usually building gradually over several weeks of twice-daily use, followed closely by reports of softer-looking fine lines and deeper hydration. Smoother texture, a brighter complexion, and — with continued use — a more even skin tone are also frequently mentioned, though community opinion is split on pigmentation: some with existing dark spots say they prefer caution because copper is involved in pigment-making pathways. On the scalp, people using copper-peptide serums often report less hair shedding and thicker-feeling hair over several months, generally as a supportive add-on rather than a stand-alone treatment. A smaller group in research-peptide communities describes injecting reconstituted GHK-Cu rather than applying it topically and reports skin or recovery benefits from that route — but there is no validated human data behind those accounts, and they sit well outside the well-documented topical, cosmetic-use literature.

On the downside, the most common complaint by far is irritation — redness, itching, or dryness — usually linked to starting at too high a concentration or using it too often. A minority describe a short breakout or "purging" phase, and a small number report a nicknamed effect, the "copper uglies," where skin looks temporarily duller rather than better. Layering copper peptides with vitamin C or strong acids in the same step is widely reported to cause irritation or to make the product seem to stop working — attributed to the copper complex breaking down chemically when combined with those actives.

Cited safety cautions from the literature:

• Injectable and systemic use is unapproved and unstudied in humans. Topical Copper Tripeptide-1 has a long cosmetic safety record, but taking GHK-Cu into the body by injection for any purpose has no validated human pharmacokinetic basis — the closest available data is a rat study showing the free peptide breaks down quickly in the bloodstream. Community injection protocols are not grounded in human evidence ^[1].
• Theoretical copper-accumulation risk with prolonged systemic use. Repeatedly taking copper into the body could in principle disturb copper-zinc balance, which matters most for people with copper-handling conditions such as Wilson's disease — though no human copper-toxicity case has been tied to GHK-Cu in the published record, and this does not apply to ordinary topical use.
• Possible pigmentation changes for people prone to dark spots, since copper supports the tyrosinase enzyme that drives melanin production; laboratory work has shown a copper peptide can raise tyrosinase activity and melanin output in pigment-cell cultures.
• Skin irritation, more likely at high concentrations or with frequent application, especially in sensitive skin.
• Avoid combining with vitamin C or strong exfoliating acids in the same step — these can break apart the copper-peptide complex chemically, wasting both products and increasing irritation ^[4].
• Human evidence is comparatively strong for a cosmetic peptide but still limited in scope — the strongest data are small topical dermatology and hair trials, and much of the broader anti-aging and gene-level literature traces back to a small number of research groups, so sweeping anti-aging claims outrun what has actually been confirmed in large human studies ^[4].

Where it fits in Skin & Aesthetics research

GHK-Cu is the anchor compound on this site — the one with the longest cosmetic-safety track record and the most controlled human data, including an actual placebo-controlled hair-growth trial ^[3]. It is also the shared ingredient inside the GLOW blend, which pairs it with two additional repair-focused peptides on the theory that matrix-building, vascular, and cell-migration signals work better together — a combination that has never itself been tested in a trial. Melanotan II sits in a different part of the skin-aging picture entirely, targeting pigment rather than collagen, through a mechanism with a considerably heavier safety burden. See the comparison page for how the three line up side by side.